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a  b  s  t  r  a  c  t
In this  study,  ﬂue  gas  from  a power  plant  smokestack  was  applied  to  culture  Spirulina  platensis  microalgae.
Our  results  will  not  only  achieve  the  ﬁxation  of carbon  from  the  emissions,  products  can  also  be produced
from  the  algal  biomass  that possess  physiological  activities  which  could  be beneﬁcial  to  human  health.
An  improved  one-step  process  of  chromatography  was  used  to produce  high-purity  C-phycocyanin  with
a PC  ratios  >3.5.  Adding  different  concentrations  of  ammonium  sulfate  produced  different  amounts
of  C-phycocyanin,  with  40%  generating  the  highest  yield,  followed  by 35%  and  30% concentrations.
Immunomodulating  activities  were  evaluated  in  the  murine  macrophage  cell  line  J774A.1.  We  found  that
C-phycocyanin  had  the  capability  to induce  secretion  of  inﬂammatory  cytokines,  including  TNF-,  IL-1,
and  IL-6,  and  that  these  results  were  not  due to contamination  with  LPS.  Treatment  with  C-phycocyanin
also  increased  proIL-1  and  COX-2  protein  expression  dose-dependently.  Furthermore,  C-phycocyanin
rapidly  stimulated  phosphorylation  of inﬂammatory-related  signaling  molecules,  including  ERK,  JNK, p38
and  IB.  In addition,  although  C-phycocyanin  decreased  production  of  LPS-induced  ROS,  it did  not  inhibit
LPS-induced  inﬂammatory  cytokines  in J774A.1  cells.  This  is the  ﬁrst report  to show  that C-phycocyanin
exhibited  a detailed  molecular  mechanism  of  bioactivity  by boosting  immunomodulation  performance.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).. Introduction
Because of the excessive discharge of global CO2 emissions,
e are facing an ever more serious greenhouse effect and other
nvironmental problems. In addition to limiting CO2 emissions
ithin reasonable constraints, the conversion of carbon sources
nto usable chemicals or sustainable energy sources is becoming
 focus of the utilization of global biomass resources. In our previ-
us study which is using ﬂue gas from a power plant smokestack
o mass-culture Spirulina platensis microalgae in a photobioreactor
∗ Corresponding author. Tel.: +886 422053366 5311.
E-mail addresses: lkpchao@yahoo.com.tw (L.K.-P. Chao),
eichin3@yahoo.com.tw (P.-C. Liao).
1 Co-ﬁrst authors.
ttp://dx.doi.org/10.1016/j.procbio.2014.05.006
359-5113/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article un[1]. This will not only achieve the ﬁxation of carbon from the emis-
sions products can also be produced from the algal biomass that
possess physiological activities which could be beneﬁcial to human
health.
Since ancient times, S. platensis has been utilized as a food or
food supplement for humans. In recent years, there has been a trend
toward using the algal products in functional food items or as raw
materials for cosmetic products. Phycocyanin, the active compo-
nent of S. platensis, is a colorant present in cyanobacteria and red
algae. Upon puriﬁcation, phycocyanins show a brilliant blue color
in solution. Phycocyanins are composed of two subunits  and 
combined together [2–4]. In nature, it exists as monomers, trimers
or hexamers; small quantities of oligomers have been found as well
[5]. In general, phycocyanins include C-phycocyanin and allophy-
cocyanin. They possess different maximum absorption peaks, 620
and 650 nm,  respectively. Studies have suggested that the ratio of
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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encountered the problem of LPS contamination. Reagents and utensils for the338 H.-W. Chen et al. / Process B
bsorbance at 620 and 280 nm can be employed to indicate the
urity of C-phycocyanin, while the ratio of absorbance at 650 and
80 nm can indicate the purity of allophycocyanin [6].
In addition, because of their special bioactivities they are
ncreasingly recognized as potential raw materials for making food
roducts that are beneﬁcial to health [7]. Many studies have indi-
ated that phycocyanins have bioactivities that include anti-tumor,
ntioxidant, and anti-inﬂammatory effects [8–13]. Several earlier
tudies indicated that C-phycocyanin has antioxidant and anti-
nﬂammatory efﬁcacies [12,14–16]. Other reports indicated that
-phycocyanin has anticancer bioactivity [17,18]. In 2003, a study
y Reddy et al. demonstrated that C-phycocyanin could reduce
he proliferation of macrophages (RAW 264.7) with increasing
osages [15]. In addition, C-phycocyanin was found to be able to
electively suppress COX-2 and PGE2 expression when RAW 264.7
acrophages were stimulated by lipopolysaccharides (LPS), thus
emonstrating the anti-inﬂammatory capability of C-phycocyanin.
Research on immunomodulation by natural products is a con-
ern for anti-infective therapies and health care. It is well-known
hat macrophages play an important role in ﬁrst-line immunologi-
al defense against host infections in mammals, and destroy tumor
ells through the secretion of various cytokines [19]. In an immune
esponse, the macrophages directly destroy foreign microorgan-
sms and tumor cells by secreting a variety of cytokine mediators,
uch as interleukin-1  (IL-1), tumor necrosis factor- (TNF-),
nterleukin-6 (IL-6), etc. IL-1 can prompt the proliferation of T-
ells, induce B-cells to produce antibodies, and boost the cytotoxic
unctions of CTL (cytolytic T lymphocytes) and NK (natural killer)
ells. IL-6, on the other hand, stimulates the liver to produce acute-
hase proteins, and stimulates B-cell proliferation; whereas TNF-
as direct cytotoxic and growth-suppression effects against tumor
ells [20–22].
Several obstacles exist in the puriﬁcation process of C-
hycocyanin [23–25]. First of all, when algal yield is high, the
-phycocyanin purity tends to be low. However, if high purity
-phycocyanin is desired, the experimental procedure is rather
omplicated and entails a high production cost. Some studies have
een carried out with phycocyanin, but there has often been a lack
f elucidation of the cell molecular mechanism [26,27]. Thus, the
ain focus of the present study was on rapid puriﬁcation of phy-
ocyanin from S. platensis and analysis of its bioactivities.
. Materials and methods
.1. Chemicals and antibodies
LPS (from E. coli 0111:B4), polymyxin B (PMB), monoclonal anti-MAP kinase,
ctivated (diphosphorylated ERK) antibody, monoclonal anti-JNK kinase, activated
diphosphorylated JNK) antibody, monoclonal anti-p38 MAP  kinase, activated
diphosphorylated p38) antibody, monoclonal anti-actin antibody and commer-
ial  C-phycocyanin were purchased from Sigma–Aldrich (St. Louis, MO,  USA). A
ouse IL-1, TNF- and IL-6 ELISA (enzyme-linked immunosorbent assay) kit
as  purchased from R&D Systems (Minneapolis, MN,  USA). Anti-IL-1 polyclonal
ntibody, anti-IB- antibody, anti-phospho-IB- antibody, anti-COX-2 antibody,
nti-rabbit IgG-HRP, and anti-mouse IgG-HRP were obtained from Santa Cruz
iotechnology (Santa Cruz, CA, USA).
.2. Extraction of crude phycocyanin from S. platensis
S. platensis microalgae were cultured in the three-dimensional photobioreactor
t  the Dalin power plant in southern Taiwan [1]. A simple repetitive freeze-and-thaw
rocess was  applied to degrade the cell walls of S. platensis microalgae.
.3. Puriﬁcation of pure C-phycocyanin from crude phycocyanin
Then, using ultrasonic vibratory treatment in PBS, crude C-phycocyanin was
issolved. In brief, 20 g (oven-dried) of S. platensis biomass was soaked at room
emperature in 300 ml  of PBS (1 L of PBS contained 137 mmol  of NaCl, 2.7 mmol of
Cl, 10 mmol  of Na2HPO4, and 1.76 mmol  of KH2PO4; pH = 7.4); then the solution
as  placed in an ultrasonic bath (Branson 5510), sonicated and extracted for 2 h. The
olution was placed in a −80 ◦C freezer for 24 h, then deiced at room temperatureistry 49 (2014) 1337–1344
and centrifuged using an ultracentrifuge at 4 ◦C (12,000 rpm, 30 min). To the super-
natant, a series of (NH4)2SO4 (30, 35 and 40%) were added separately to salt out
the protein. After repeating 4 ◦C ultracentrifugation (12,000 rpm, 30 min), the pre-
cipitated protein fraction was re-dissolved with PBS and ﬁltered through a 0.22 m
membrane. Dialysis was carried out using a Spectra/Por® membrane (Spectrum Lab-
oratories, Rancho Dominguez, CA, USA) with a molecular weight cutoff of 1 kDa.
Water was replaced with fresh deionized water twice daily for 2 days. The resulting
C-phycocyanin was then freeze-dried and quantiﬁed. Two hundred mg  of crude C-
phycocyanin (PC ratios ca. 0.8) was weighed and redissolved in PBS. Then a GPC 1122
liquid chromatography solvent delivery system (LC Tech, Dorfen, Germany) ﬁtted
with a HiPrep 26/60 SephacrylTM S-300 high-resolution column (GE Healthcare Bio-
Sciences, Uppsala, Sweden) was used to purify C-phycocyanin. The conditions of
isolation were: each injection amount was 5 ml, elution solution was 1 × PBS (con-
taining 0.05% NaN3), the ﬂow rate of eluent was  set at 3.0 ml/min, and 260 s per tube
was collected. C-phycocyanin from the ﬁfth tube on a UV-vis spectrophotometer
(Agilent 8453; Agilent Technologies, Santa Clara, CA, USA) was used to determine
the  PC ratios (A620/A280) of the contents. For PC >2.0, the fraction was  separately
collected, then dialysis was repeated (Spectra/Por® membrane, molecular weight
cutoff 1 kDa); every 12 h the water was replaced. After three exchanges, the post-
dialysis phycocyanin was  freeze-dried, collected separately and quantiﬁed. In order
to  increase the separation efﬁciency, the NaCl concentration gradient of the eluent
added was from 0 mM to 30 mM.
2.4. Cell cultures
J774A.1 murine macrophages obtained from the Bioresource Collection and
Research Center (Taiwan, ROC) were propagated in RPMI 1640 medium supple-
mented with 10% heat-inactivated fetal bovine serum (FBS; HyClone, Logan, UT,
USA) and 2 mM L-glutamine (Invitrogen Life Technologies, Carlsbad, CA, USA), and
cultured at 37 ◦C in a 5% CO2 incubator.
2.5. Cell toxicity of C-phycocyanin
Cell proliferation was determined using an MTT  assay [28]. J774A.1 macrophages
were seeded in 96-well plates at a density of 5 × 103 cells/well. Cells were incu-
bated with C-phycocyanin (50–400 g/ml) for 24 h. The value was  determined by
averaging triplicate sample measurements.
2.6. Western blotting analysis
Whole cell lysates or C-phycocyanin samples were separated by 12% SDS-PAGE
and  electrotransferred to a polyvinylidene ﬂuoride (PVDF) membrane. The mem-
brane was incubated in blocking solution (5% nonfat milk in PBS with 0.1% Tween
20) at room temperature for 1 h, and then incubated at room temperature for 2 h with
anti-proIL-1 antibody, anti-MAP kinase antibody, diphosphorylated ERK-1 and -2
antibody, anti-JNK kinase antibody, anti-p38 MAP  kinase antibody, anti-COX-2 anti-
body, or anti-IB antibody. After washing three times in PBS with 0.1% Tween 20,
the membrane was  incubated with an HRP-conjugated secondary antibody directed
against the primary antibody. The membrane was developed by an enhanced chemi-
luminescence Western blotting detection system (DuPont NEN Research Products,
Boston, MA, USA) according to the manufacturer’s instructions [29].
2.7. Enzyme-linked immunosorbent assay (ELISA)
In the dose response study, J774A.1 cells (1 × 106/ml) were stimulated with
C-phycocyanin only or with C-phycocyanin and LPS for determining TNF- and
IL-6 (after 6 h) and IL-1 (after 24 h). The concentration of cytokines in the con-
ditioned medium was  analyzed by ELISA according to the manufacturer’s protocol,
using Quantikine® mouse TNF-, IL-6 and IL-1 immunoassay kits (R&D Systems)
[30]. Biotinylated antibody reagent (50 L) and 50 L supernatant concentrate from
samples tested for various times were added to anti-mouse TNF-, IL-6 and IL-1
precoated stripwell plates, followed by incubation at room temperature for 2 h. After
washing the plates three times with the washing buffer provided, 100 L diluted
streptavidin-HRP concentrate was  added to each well and incubated at room tem-
perature for 30 min. The washing process was repeated; then 100 L premixed TMB
substrate solution was  added to each well and developed at room temperature in
the dark for 30 min. Following the addition of 100 L provided stop solution to each
well to stop the reaction, the absorbance of the plates was measured by a Gem-
ini EM microplate spectroﬂuorometer (Molecular Devices, Sunnyvale, CA, USA) at
450–550 nm wavelengths.
2.8. Monitoring of LPS contamination of C-phycocyanin in experiments
Previous studies of C-phycocyanin-mediated reactions and signaling havepreparation of C-phycocyanin were either LPS-free grade or were washed with
PBS containing 10 g/ml PMB, then rinsed with PBS. In order to rule out possi-
ble  LPS contamination of C-phycocyanin samples, J774A.1 cells were pre-incubated
with or without PMB  (10 g/ml) for 30 min, followed by treatment for 6 h with
C-phycocyanin (400 g/ml) or 24 h with LPS (0.03, 0.1, 0.3 or 1 g/ml).
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prove that the C-phycocyanin obtained in the study was  not merely
proven using the PC ratios, but the SDS-PAGE was engaged to prove
that the purity of C-phycocyanin was similar to the purchased high-
purity product from Sigma Chemicals; that the  and  subunits ofFig. 1. The ﬂow di
.9. Antioxidant activity of C-phycocyanin
The antioxidant activity of C-phycocyanin was determined by intracellular H2O2
timulated by C-phycocyanin, which was measured by detecting the ﬂuorescence
ntensity of chloromethyl-2′ ,7′-dichloroﬂuorescin (CM-DCF), the oxidized product
f  chloromethyl-2′ ,7′-dichlorodihydroﬂuorescein diacetate (CM-H2DCDA) (Molec-
lar Probes, Eugene, OR, USA). Brieﬂy, J774A.1 cells (1 × 106/ml) grown in serum-
nd phenol red-free RPMI medium for 24 h were then preincubated with CM-
2DCDA (2 M)  and N-acetyl cysteine (NAC) (10 mM)  at 37 ◦C for 30 min  in the dark.
his was  followed by adding fresh starvation medium containing C-phycocyanin
50–400 g/ml) or LPS (1 g/ml) for an additional time, as indicated above. The
elative ﬂuorescence intensity of the ﬂuorophore CM-DCF, which was formed by
eroxide oxidation of the nonﬂuorescent precursor, was detected at an excitation
avelength of 485 nm and an emission wavelength of 535 nm with a Gemini EM
icroplate spectroﬂuorometer (Molecular Devices).
.10. Statistical analysis
All values are given as mean ±SD. Statistical analysis was  performed by ANOVA
or analysis and followed by suitable post hoc Duncan’s multiple range test (DMRT)
est was  applied to calculate the statistical signiﬁcance between various groups. A
alue of P < 0.05 was  considered to be statistically signiﬁcant.
. Results
.1. Isolation and puriﬁcation of C-phycocyanin
A notable feature of the present study was that the puriﬁcation
f C-phycocyanin was not as complicated as those described in ear-
ier studies. The process merely involved dissolving C-phycocyanin
nd protein from S. platensis using phosphate buffered saline
PBS); then a 40% (NH4)2SO4 solution was added to salt out crude
-phycocyanin. Upon ﬁltration using a 0.22 m membrane, the
roducts were freeze-dried and quantiﬁed. A gel-ﬁltration column
as used to obtain pure C-phycocyanin with PC ratios >3.5. The
ow diagram of the procedure is shown in Fig. 1.
Table 1 shows that by using different concentrations of ammo-
ium sulfate, different yields of C-phycocyanin were obtained. The
0% group produced the highest yield. C-phycocyanin obtained
ith different ammonium sulfate concentrations were separately
ollected at PC fraction ratios of 2.5, 3.0, 3.5 and >3.5. The results
ndicated that the higher ammonium sulfate concentration, the
reater C-phycocyanin yield. However, regardless of ammonium of the procedure.
sulfate concentrations, the higher PC ratios of the fraction, the lower
yield became. In addition, Table 1 also shows the average precipi-
tation yields of C-phycocyanin respectively with 30%, 35%, and 40%
ammonium sulfate solution, which were respectively 6.54%, 8.37%,
and 15%. The average fractional yields (in mg)  of C-phycocyanin
with different PC ratios are shown at the lower right corner of
Table 1.
The spectra and absorbance values of different puriﬁed C-
phycocyanin fractions collected are showed in Fig. 2A. After fraction
17, the PC ratios decreased rapidly to less than 2.5. Test specimens
collected after fraction 14 were subjected to SDS electrophoresis
(Fig. 2B). In the ﬁgure, line 1 was  from the standard purchased from
Sigma–Aldrich, which had a PC ratios >3.5. Line 2 was  our puri-
ﬁed C-phycocyanin, having a PC ratio of 3.51. Fig. 2A and B was toFig. 2. Purity of C-phycocyanin from Spirulina platensis. (A) UV–vis spectra and PC
ratios of different fractions of crude C-phycocyanin after liquid chromatographic
puriﬁcation using a SephacrylTM S-300 high-resolution column. (B) SDS-PAGE of
puriﬁed C-phycocyanin (fraction 14) vs. standard (Sigma–Aldrich), both with PC
ratios >3.5.
1340 H.-W. Chen et al. / Process Biochemistry 49 (2014) 1337–1344
Table 1
C-phycocyanin (C-PC) yields (%) and the weights of collected from different PC ratios by using different ammonium sulfate concentrations.
PC ratios (A620/A280)
2.5 3.0 3.5 >3.5
30% (NH4)2SO4, C-PC avg. yields (6.54%) 9.0 mg 7.25 mg  1.87 mg  0.5 mg
35%  (NH4)2SO4, C-PC avg. yields (8.37%) 12.5 mg 4.75 mg  3.25 mg  0.75 mg
40%  (NH4)2SO4, C-PC avg. yields (11.35%) 15.0 mg 5.75 mg  5.0 mg 1.75 mg
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sote: Each injection was  5 ml;  the crude C-phycocyanin dissolved was ca. 200 mg. T
hycocyanin average yield (in parentheses), which provides the actual C-phycocyani
ere  based on at least ﬁve replications. The average yields for different PC values w
-phycocyanin had identical positions and we have remarked the
 and  subunits of C-phycocyanin in Fig. 2B. These experimental
esults indicated that using the experimental procedure produced
eliable high-purity C-phycocyanin.
.2. Cytotoxicity and immunomodulation activity of
-phycocyaninPrior to investigating the bioactivity of C-phycocyanin, an MTT
ssay was used to test for cytotoxicity. The results revealed that
hen C-phycocyanin (400 g/ml) or LPS (1 g/ml) were added to
ells, followed by incubation for 24 h, no cell death occurred. The
ig. 3. Cytotoxicity and effects of C-phycocyanin on LPS-stimulated inﬂammatory mediato
B)  and (C) J774A.1 macrophages subjected to treatment with C-phycocyanin (C-PC, 0–40
mount of TNF- (B), IL-6 (C) in culture medium was  assayed by ELISA. (D) Secreted amou
C-PC,  0–400 g/ml) for 30 min, then with 1 g/ml of LPS followed by incubating for 24 h.
re  expressed as mean ± SE from three separate experiments. (E) J774A.1 macrophages (1
ollowed by stimulating with 1 g/ml of LPS for 6 h. The expression of pro-IL1 and COX
hown.ld must be multiplied by the original ammonium sulfate-precipitated S. platensis C-
. Average yields of S. platensis C-phycocyanin from ammonium sulfate precipitation
ased on 10 replications after LC puriﬁcation.
particular dosage of both C-phycocyanin (25–400 g/ml) and LPS
had no bearing on cytotoxicity (Fig. 3A).
Infection by pathogenic bacteria will cause inﬂammatory
cytokines such as TNF-, IL-1 and IL-6 or their modulating fac-
tors to increase, which in severe cases may  lead to the death of
patients. Previous studies have shown that C-phycocyanin con-
tains anti-inﬂammatory capability in LPS-stimulated RAW 264.7
macrophages [15,31]. In order to examine whether C-phycocyanin
puriﬁed from S. platensis has anti-inﬂammatory activity in murine
J774A.1 macrophages during an infection process, we  ﬁrst added
different doses of C-phycocyanin to macrophages, incubated them
for 30 min, and then added LPS (1 g/ml) followed by incubation
for 6–24 h. Fig. 3B–D shows that in murine macrophages pretreated
rs. (A) Cell toxicity of f C-phycocyanin (C-PC) was  assayed by Alarmar Blue method.
0 g/ml) for 30 min, followed by stimulating with 1 g/ml of LPS for 6 h. Secreted
nt of IL-1 from J774A.1 macrophages subjected to treatment with C-phycocyanin
 The cytokine concentration in culture medium was  assayed by ELISA method. Data
 × 106/ml) were pretreated with 0–400 g/ml of C-phycocyanin (C-PC) for 30 min,
-2 was assayed by Western blot. The result of one of three separate experiments is
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ith C-phycocyanin, there was no signiﬁcant suppression of the
xpression of TNF-, IL-1 and IL-6. In LPS-stimulated cells, the
ecretion amount of TNF- was 24 ng/ml. Under pretreatment
onditions using 50, 100, 200 and 400 g/ml of C-phycocyanin,
owever, the ensuing TNF- was 34, 36, 41 and 47 ng/ml, respec-
ively (Fig. 3B). LPS stimulation alone caused IL-6 secretion
f 10 ng/ml, whereas with pretreatments of 50, 100, 200 and
00 g/ml of C-phycocyanin, the secretion of IL-6 rose to 11, 12,
3 and 16 ng/ml (Fig. 3C). From stimulation by LPS alone, IL-
 expression was 130 pg/ml; whereas after pretreatment with
he aforementioned C-phycocyanin doses, the expression levels
ncreased to 131, 135, 139 and 151 pg/ml, respectively (Fig. 3D).
e also used western blotting to test protein expression of
nﬂammatory-related proteins, include proIL-1 and COX-2. As
hown in Fig. 3E, J774A.1 macrophages were pretreated with
–400 g/ml of C-phycocyanin for 30 min; then cells were stim-
lated with 1 g/ml of LPS, followed by incubation for 6 h. The
esults indicated that there was no discernible suppression of the
xpression of proIL-1 and COX-2 as stimulated by LPS.
These results differed from those of Cherng et al. [31], which
howed that in a RAW 264.7 (murine microphage) cellular model,
he presence of C-phycocyanin could signiﬁcantly suppress the
xpressed amount of iNOS and NF-B activation stimulated by
PS (120 g/ml). Their results indicated that C-phycocyanin has
he capacity to suppress production of cytokines when murine
AW 264.7 macrophages were stimulated by LPS. Because our
ata differed from a previous study [31], we next investi-
ated whether C-phycocyanin contains other bioactivity, such as
mmunomodulation. To examine the immunomodulation activi-
ies of C-phycocyanin, J774A.1 macrophages were treated with
–400 g/ml of C-phycocyanin for 6 h; the secretion of cytokines
n the medium was tested using an ELISA method. To exclude the
ossibility of LPS contamination, cells were co-treated with PMB,
 cyclic amphipathic peptide antibiotic that binds to endotoxins.
s shown in Fig. 4A, the secreted amount of TNF- increased with
ncreasing amounts of C-phycocyanin. However, even after adding
0 g/ml of PMB, the expressed amount of TNF- boosted by C-
hycocyanin was not totally suppressed. Fig. 4B shows the effects
f adding 50–400 g/ml C-phycocyanin on the production of IL-6
y the J774.1 cells. The trend was similar to that in Fig. 4A. The effect
f C-phycocyanin stimulation of J774.1 macrophages on the expres-
ion of IL-1 is shown in Fig. 4C. Notably, at a 50 g/ml dose, there
as no IL-1 production; but at 100–400 g/ml C-phycocyanin
oses there was signiﬁcant activation of IL-1 secretion. Addi-
ionally, when only C-phycocyanin (400 g/ml) without LPS was
dded to J774A.1 macrophage culture, the expression of COX-2 was
ncreased dose-dependently; while proIL-1 expression was  only
etected after adding a 400 g/ml dose of C-phycocyanin (Fig. 4D).
When added alone, a 400 g/ml dose of C-phycocyanin caused
nly a mild expression of TNF- (Fig. 4A), unlike that induced by a
eneral pathogen (antigen) that releases large amounts of inﬂam-
atory cytokines. In other words, the expressed amount was not
ery high: less than half of what 0.03 g/ml of LPS could induce
Fig. 4E). Therefore, C-phycocyanin evidently possesses bioactivity,
.e. the ability to modulate immune cells in mammals. Cytokines
uch as IL-1ß could prompt the proliferation of T-cells, induce B-
ells to produce antibodies, and boost the cytotoxic functions of
TL (cytolytic T lymphocytes) and NK (natural killer) cells. IL-6
timulates the liver to produce acute-phase proteins and B-cell
roliferation; whereas TNF- has direct cytotoxic and growth-
uppression effects against tumor cells.
These results, however, differed somewhat from the ﬁndings
f previous reports [15,31]. In their study, the C-phycocyanin was
rom Sigma–Aldrich and the PC was >3.5. Therefore, in this study
 comparison was made of the differences in bioactivities between
ommercial C-phycocyanin (purchased from Sigma–Aldrich) andistry 49 (2014) 1337–1344 1341
C-phycocyanin puriﬁed from Spirulina grown in a photobioreac-
tor. First of all, the commercial C-phycocyanin was a liquid with
fair amount of salts, including EDTA and PBS (155 mM).  In addi-
tion, after adding commercial C-phycocyanin alone (50 g/ml) the
J774A.1 murine macrophages had only a 75% survival rate (data not
shown). If the C-phycocyanin (50 g/ml) was added 30 min before
LPS stimulation, the cellular survival rate increased to 89%. Con-
versely, when C-phycocyanin puriﬁed from Spirulina was  added at
400 g/ml dose, there was  no cell death. Apparently, without dial-
ysis, the commercial C-phycocyanin preparation might be slightly
cytotoxic. At the same dose (50 g/ml), however, we found no
apparent suppression effect on the production of TNF- by J774A.1
murine macrophages when commercial C-phycocyanin was used
(data not shown).
3.3. Monitoring of LPS contamination of C-phycocyanin in
experiments
In order to conﬁrm the immunomodulating effects of C-
phycocyanin and ascertain that the puriﬁed C-phycocyanin from
S. platensis was  not contaminated with LPS, a set of experiments
was designed to prove the authenticity of the experimental results.
As shown in Fig. 4E, LPS was  diluted separately to 0.03, 0.1, 0.3 and
1 g/ml to stimulate the J774A.1 macrophages; then 10 g/ml of
PMB  (a polypeptide antibiotic with a positive charge, which is often
used to suppress the cytokines stimulated by LPS in in vitro studies)
was added separately to suppress the expression of the inﬂamma-
tory cytokine TNF-. The results indicated that 10 g/ml of PMB
could totally suppress the production of TNF- at LPS doses of 0.03,
0.1 and 0.3 g/ml; however, it failed to totally suppress the expres-
sion of TNF- after a 1 g/ml dose of LPS (the expressed amount
was 200 pg/ml). When cells were stimulated by C-phycocyanin
(400 g/ml), the expression of TNF- increased to 300 pg/ml; and
after the further addition of 10 g of PMB, the TNF- decreased
only slightly, to 250 pg/ml. These results clearly show that the TNF-
 produced by C-phycocyanin was affected only minimally by PMB.
This may  primarily be due to the charged nature of the protein. If
the C-phycocyanin contained an extremely low concentration of
LPS, then its existence in the C-phycocyanin must be >0.075%. Even
if this were true, then 10 g/ml of PMB  can totally suppress the
expression of TNF-. Therefore, the experimental results should be
construed as proof that our C-phycocyanin was  totally free from
contamination by LPS, and that the results were a manifestation
purely of C-phycocyanin induction on the J774A.1 macrophages.
3.4. Activation of MAPK and NF-B signaling pathways by
C-phycocyanin
MAPKs and NF-B signaling are involved in cytokine secre-
tion and proinﬂammatory molecule expression in macrophages.
A dosage of 400 g/ml of C-phycocyanin applied to J774A.1
cells appeared to activate the mitogen-activated protein kinases
(MAPKs) ERK, JNK and p38 by phosphorylation. After 10 and 60 min
of treatment, phosphorylation of IB was  detected. As is well
known, after phosphorylation, IB will be degraded by protea-
somes; this allows NF-B to enter the nucleus. The results of this
experiment suggested that C-phycocyanin indeed possesses bioac-
tivity, and is able to modulate murine macrophages (Fig. 5).
3.5. Antioxidant activity of C-phycocyanin
A previous study has demonstrated that C-phycocyanin contains
antioxidant properties [10]. Fig. 6 shows the antioxidant effects
of C-phycocyanin-pretreated J774A.1 cells. LPS stimulation of cells
rapidly induces ROS production when compared with that of con-
trol cells. In contrast, pretreatment with N-acetylcysteine (NAc), a
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Fig. 4. Effect of C-phycocyanin (C-PC) on the expression of inﬂammatory mediators. (A)–(C) J774A.1 macrophages were treated with C-phycocyanin (C-PC, 0–400 g/ml)
for  6 h or 24 h in the absence or presence of 10 g/ml PMB. TNF- (A), IL-6 (B), IL-1 (C) concentration in culture medium was assayed by ELISA. Data are expressed as
mean  ± SE from three separate experiments. (D) J774A.1 cells were treated with 0–400 g/ml of C-phycocyanin (C-PC) for 6 h. Cells lysates were separated by 10% SDS–PAGE
and  immunoblotted with anti-pro-IL1 and anti-COX-2. Shown are representative blots of at least three repeats at all data points. (E) J774A.1 cells were pretreated with LPS
(0.03–1 g/ml) or C-phycocyanin (C-PC, 400 g/ml) for 6 h in the absence or presence of 10 g/ml PMB. The TNF- concentration in culture medium was measured by ELISA.
Fig. 5. Effect of C-phycocyanin on MAPKs phosphorylation and NF-B activation.
J774A.1 cells were treated with C-phycocyanin (C-PC, 400 g/ml) for 0–60 min. The
phosphorylation levels of ERK1/2, JNK1/3 and p38 were analyzed by Western blot.
Data are from one of the representative experiments (n = 3).
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Fig. 6. C-phycocyanin inhibited ROS release in J774A.1 macrophages stimulated
with LPS (1 g/ml). Cells were pretreated with H2DCFDA (2 M)  for 30 min, fol-
lowed by substitution with fresh medium. Cells were treated with C-phycocyanin
(C-PC, 0–400 g/ml) or with N-acetyl cysteine (NAC) (10 mM)  for 30 min, prior to
incubation with LPS (1 g/ml) for 0–60 min. The relative ﬂuorescence intensity of
ﬂuorophore CM-DCF was detected as described in Section 2. Data are expressed as
mean ± SEM of three independent experiments.
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otent antioxidant, quickly reduces the production of LPS-induced
OS. Along with increasing dosages of C-phycocyanin, the ROS
H2O2) content in cells was decreased within 2 h.
. Discussion
In Table 1, our results demonstrated that higher concentration
f ammonium sulfate resulted in higher yields of C-phycocyanin of
igher PC ratios. Comparing the 40% and 30% ammonium sulfate,
he yield gain was less than 2-fold (11.35% vs. 6.54%), however,
he fraction of C-phycocyanin with PC ratios >3.5 were 1.75 mg
s. 0.5 mg;  for product of PC ratio = 3.5, the yields were 5.0 mg
s. 1.87 mg.  Apparently, the high concentration of ammonium sul-
ate was an important factor in favoring products of high PC ratios
i.e., produced higher yield and greater purities). This experimen-
al study showed that C-phycocyanin isolated from S. platensis
icroalgae possesses immunomodulatory activity. In this study the
xperimental results proved that puriﬁed C-phycocyanin induced
ecretion of immune cytokines such as TNF-, IL-1 and IL-6, and
egulated intracellular proteins such as proIL-1, COX-2, phos-
horylated I, and MAPK in J774A.1 murine macrophages. In
ddition, C-phycocyanin contained antioxidant activity. However,
-phycocyanin produced no apparent anti-inﬂammatory bioactiv-
ty in a J774A.1 murine macrophage model.
In our previous study, a novel photobioreactor was developed
hich is utilizing CO2 in the ﬂue gas of a power plant as the carbon
ource for the growth of a seawater alga, S. platensis. This will not
nly accomplish the ﬁxation of carbon from the emissions; prod-
cts can also be produced from the algal biomass that possesses
hysiological activities. Otherwise, microbial decomposition will
uickly return the ﬁxed carbon back into the atmosphere. Addi-
ionally, in the process of treating biomass for reutilization, the
ecessary energy requirements and ensuing CO2 emissions must
e taken into account in order to avoid overloading the environ-
ent. Nevertheless, the culturing of algal biomass is likely to have
 positive overall signiﬁcance in carbon sequestration. Regardless of
hether the biomass is used as a health food supplement or as ani-
al  feed, carbon will be ﬁxed in biological entities as a consequence.
herefore, further efforts toward understanding the bioactivities of
uch biomass are warranted.
Many studies have traditionally used the ratio of absorbance
t 620 and 280 nm to express the purity of C-phycocyanin. In
 paper by Pin˜ero Estrada et al., a hydroxyapatite column was
rst used to purify phycocyanin, and then a DEAE Sephadex A-50
Sigma–Aldrich) gel-ﬁltration column to further purify the prod-
ct [32]. They obtained a product with an A620/A280 nm ratio of
pproximately 3.9. Other studies have used an absorbance ratio of
615/A280 nm as an indication of C-phycocyanin purity [7]. How-
ver, their reported C-phycocyanin purities were all quite low
>0.5).
Chaiklahan et al. successfully utilized a membrane process to
xtract phycocyanin en masse from a Spirulina sp. using ultra-
ltration. Although the procedure produced larger quantities of
hycocyanin, the PC purity value was only ca. 1.07, and thus
ot very high [4,33]. Unlike some prior studies, which generally
ere run at a 50% concentration of ammonium sulfate, relatively
ower concentrations were used. In the present study it was found
hat with increasing ammonium sulfate concentration, the yield of
rude phycocyanin tended to increase; however, non-target mot-
ey proteins of other origin also increased in the solution. Thus,
lthough the total protein extraction increased, the puriﬁcation
rocess became more complicated as well. As a consequence, a 40%
oncentration of ammonium sulfate was used to precipitate crude
-phycocyanin. Ammonium sulfate solutions of 30 and 35% tended
o produce too low a yield, however.istry 49 (2014) 1337–1344 1343
In this study a murine macrophage cell line, J774A.1, was
employed as an experimental model. The results showed that
the C-phycocyanin puriﬁed from S. platensis, when applied to a
murine J774A.1 macrophage model, exhibited bioactivity by boost-
ing immunomodulation performance, and had the capability of
inducing the expression of TNF-, IL-1, IL-6, proIL-1 and COX-2
in macrophage cells, as well as the phosphorylation of ERK, JNK,
p38 and IB. However, the results appeared to deviate from those
of Cherng et al. [31]. They showed that in a RAW264.7 (murine
microphage) cellular model, the presence of C-phycocyanin could
signiﬁcantly suppress the expressed amount of iNOS stimulated
by LPS (120 g/ml). In their study, the C-phycocyanin was  from
Sigma–Aldrich and the PC was  >3.5. They also noted that 1 h after
C-phycocyanin treatment at doses of 120–250 g/ml, the expressed
amount stimulated by LPS also showed signiﬁcant suppression;
however, C-phycocyanin treatment had no suppressive effect on IL-
1. When LPS was  added alone, IB- was degraded signiﬁcantly;
however, when C-phycocyanin was also added, the degradation
could be prevented. Their results indicated that C-phycocyanin has
the capacity to suppress production of cytokines when murine
macrophage cells were stimulated by LPS. One possible cause
of differences in the experimental results might originate from
the source of C-phycocyanin proteins. The C-phycocyanin used in
their study was from Sigma–Aldrich, while in the present study
C-phycocyanin was puriﬁed from Spirulina grown in a photobiore-
actor. Commercial C-phycocyanin shows slightly cytotoxicity and
has no suppression effect on the production of TNF- by J774A.1
murine macrophages (data not shown). In addition, there may  be
several probable causes for the discrepancy, including different cel-
lular strains. Cherng et al. [31] and Reddy et al. [15] employed RAW
264.7 murine macrophages and different LPS. (They applied an E.
coli 026:B6 strain, while in the present study an E. coli 0111:B4
strain was used.)
Because macrophage cells exist widely in various organs and
tissues of the human body, they play a vital role in immune
defense, including participating in immune response and inﬂam-
matory response, and maintaining the stability of the internal
cellular environment. However, not all these functions are exe-
cuted or expressed by macrophage cells simultaneously. Simply
put, there exists among macrophage cells certain heterogeneity.
The probable cause of this phenomenon is that macrophages are
derived from different precursor cells which originally are situated
in different growth environments [34]. In addition, different strains
of macrophage cells might differentiate because of their varying
genetic features [35]. Certain macrophage cells have an expressive
nature disassociated from environmental factors. Conversely, they
tend to react differently to certain speciﬁc stimulus cells. This is
because different stimulating factors will cause activation of differ-
ent intracellular signal transduction, resulting in macrophage cell
heterogeneity.
Several signal transduction cascades are involved in the regu-
lation of inﬂammatory mediator expression, such as MAPKs and
NF-B. Few studies have been conducted on the effects of phy-
cocyanins on MAPKs, especially with respect to immunological
cells. The present results indicated that such cells treated with
C-phycocyanin will show activation of ERK, JNK and p38 protein
expressions. In a study in a melanoma B16F10 cellular model,
adding C-phycocyanin alone could increase the expression of ERK,
but at the expense of suppressed p38 expression [36]. Nishanth
et al. [37] found that C-phycocyanin added to hepatoma cells could
suppress the content of reactive oxygen species (ROS) and COX-2,
but did not affect the expression of ERK, JNK and p38 proteins.ROS play important roles in LPS-mediated cytokine expression.
In this study, we  found that C-phycocyanin contains anti-oxidant
activity. Our results are consistent with a previous study [9,10],
although different cell strains and sources of C-phycocyanin were
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sed. It is generally accepted that ROS has an inﬂammatory effect,
nd its overproduction can cause functional chaos in cells and
rgans. A study by Zmijewski et al. [38], however, indicated that
eroxides somehow have an anti-inﬂammatory effect. Through
bservation of the suppression of peroxidase or reduction in
he induced inﬂammatory response by lipopolysaccharides, they
xplained the mechanism whereby increased peroxides in cells
ause acute inﬂammation. The results of these studies suggest that
hen the immune system is boosted, it is necessary for ROS in cells
o increase as well.
In conclusion, a moderate stimulation of macrophages by C-
hycocyanin can increase the immunological activity of cells and
llow the biological entity to obtain the beneﬁts. As far as we know,
o other paper has studied the intracellular molecular mechanisms
f C-phycocyanin activities in such detail.
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